Date & Time
Tuesday, November 1, 2022
4:00 pm - 5:00 pm ET
Location
Virtual Zoom Session
About this Session
The Pharmacokinetics, Dynamics and Metabolism (PDM) group at Pfizer is an exciting collection of various different scientific disciplines that support a molecule’s entire journey from its first discovery through the time it loses patent exclusivity. At the earliest Discovery stages, Pfizer colleagues are involved with screening to identify compounds that are active at the disease target of interest. Then, other colleagues are involved in the characterization and optimization of promising compounds’ properties before they can be safely tested in humans. Finally, another set of colleagues helps guide a molecule through its different stages of development in human testing and ultimately, its registration as a new drug. Throughout the process, other colleagues use their special expertise in modelling and simulation, still others communicate with regulatory authorities throughout the world (to name just a couple). Traditionally, Pfizer PDM has hired students with backgrounds in chemistry, biology, pharmacology and analytical chemistry, but the science is varied, and other opportunities exist.
Speakers will include:
- Tracey Boyden, Compliance, Regulatory & Bioinformatics
- George Chang, Computational ADME
- Aly Dantonio, Enzymology
- Doug Spracklin, Biotransformation
- Amy Moody Thurber, Modeling & Simulation
- James Wepy, Project Representative
Employer information sessions are a great opportunity to meet company representatives and ask any questions you might have about their organization or application process.
Register to Participate
To attend this virtual event, please RSVP using our Zoom registration form.
